(1998). A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab
(1999). A: Effect of dietary alpha-linolenic acid on thrombotic risk factors in vegetarian men.
(2006). AJ: A significant inverse relationship between concentrations of plasma homocysteine and phospholipid docosahexaenoic acid in healthy male subjects. Lipids
(2006). Brown-Borg HM: Methionine flux to transsulfuration is enhanced in the long living Ames dwarf mouse. Mech Ageing Dev
(2010). C: MAT1A variants modulate the effect of dietary fatty acids on plasma homocysteine concentrations. Nutr Metab Cardiovasc Dis
(2008). Cardiovascular pathogenesis in hyperhomocysteinemia.
(2006). Chaoshu T: Impact of L-arginine on hydrogen sulfide/cystathionine-gamma-lyase pathway in rats with high blood flow-induced pulmonary hypertension. Biochem Biophys Res Commun
(2011). D: High consumption of omega-3 polyunsaturated fatty acids decrease plasma homocysteine: A meta-analysis of randomized, placebo-controlled trials. Nutrition
(2001). Docosahexaenoic acid regulated genes and transcription factors inducing apoptosis in human colon cancer cells.
(1993). Does fish oil lower blood pressure? A metaanalysis of controlled trials. Circulation
(2007). Du JB: Imbalance of endogenous homocysteine and hydrogen sulfide metabolic pathway in essential hypertensive children. Chin Med J (Engl)
(2000). Fatty acid regulation of gene transcription.
(2010). Fish fatty acids alter markers of apoptosis in colorectal adenoma and adenocarcinoma cell lines but fish consumption has no impact on apoptosis-induction ex vivo. Apoptosis
(2010). GP: Dietary omega-3 polyunsaturated fatty acids suppress expression of EZH2 in breast cancer cells. Carcinogenesis
(1990). Hamfelt A: Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment. Atherosclerosis
(2001). Heart rate variability and n-3 polyunsaturated fatty acids in patients with diabetes mellitus.
(2004). Heinecke JW: Neuronal expression of myeloperoxidase is increased in Alzheimer’s disease.
(1998). Homocysteine and cardiovascular disease. Annu Rev Med
(1999). Homocysteine metabolism. Annu Rev Nutr
(1988). Hultberg B: Higher total plasma homocysteine in vitamin B12 deficiency than in heterozygosity for homocystinuria due to cystathionine beta-synthase deficiency. Metabolism
(2007). Hyperhomocysteinemia due to cystathionine beta synthase deficiency induces dysregulation of genes involved in hepatic lipid homeostasis in mice.
(1993). IH: Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA
(2007). Inhibition of cystathionine-gamma-lyase leads to loss of glutathione and aggravation of mitochondrial dysfunction mediated by excitatory amino acid in the CNS. Neurochem Int
(2008). Liver X receptor agonist downregulates hepatic apoM expression in vivo and in vitro.
(2007). LJ: Platelet phospholipid n-3 PUFA negatively associated with plasma homocysteine in middle-aged and geriatric hyperlipaemia patients. Prostaglandins Leukot Essent Fatty Acids
(2008). Low vitamin B6 and folic acid levels are associated with retinal vein occlusion independently of homocysteine levels. Atherosclerosis
(1971). Mammalian methylenetetrahydrofolate reductase. Partial purification, properties, and inhibition by Sadenosylmethionine. Biochim Biophys Acta
(2008). Mato JM: S-Adenosylmethionine in cell growth, apoptosis and liver cancer.
(2009). Mechanisms of action of eicosapentaenoic acid in bladder cancer cells in vitro: alterations in mitochondrial metabolism, reactive oxygen species generation and apoptosis induction.
(1984). Methionine metabolism in mammals. Distribution of homocysteine between competing pathways.
(2006). ML: Intracellular levels of S-adenosylhomocysteine but not homocysteine are highly correlated to the expression of nm23-H1 and the level of 5-methyldeoxycytidine in human hepatoma cells with different invasion activities. Nutr Cancer
(1988). MR: Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency: possible implications for prevention of vascular disease. Metabolism
(2000). Pathways and regulation of homocysteine metabolism in mammals. Semin Thromb Hemost
(2006). PK: Homocysteine hypothesis for atherothrombotic cardiovascular disease: not validated.
(2001). Polyunsaturated fatty acid regulation of gene transcription: A molecular mechanism to improve the metabolic syndrome.
(2003). The 2756A > G variant in the gene encoding methionine synthase: its relation with plasma homocysteine levels and risk of coronary heart disease in a Dutch case-control study. Thromb Res
(1994). The acute effects of a single very high dose of n-3 fatty acids on plasma lipids and lipoproteins in healthy subjects. Lipids
(2004). Ueland PM: High-level multiplex genotyping of polymorphisms involved in folate or homocysteine metabolism by matrix-assisted laser desorption/ionization mass spectrometry. Clin Chem
(1969). Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis.
(1994). Vitamin B-6 deficiency vs folate deficiency: comparison of responses to methionine loading in rats.
(1999). WC: Dietary intake of alpha-linolenic acid and risk of fatal ischemic heart disease among women.